Icon Therapeutics Large Retina

Therapeutic Areas

Rare Disease / Orphan Disease

CTI is a leader in rare disease and orphan disease research with more than 3/4 of CTI’s active prospective studies in these therapeutic areas

Learn More

Regenerative Medicine / Gene Therapy

With more the 50% of CTI's active prospective studies involving regenerative medicine, including contributing to the development program of several of the world's first approved gene therapy products, the company is a leader in the field.

Learn More

Immunology

With dozens of marketing approvals, we can support product development in immunology.

Learn More

Transplantation

CTI is a leader in this field with contributions to nearly all transplant-related therapies on the market today. Approximately 50% of our active prospective studies involves transplantation, and of these, nearly half involve regenerative medicine.

Learn More

Nephrology

With 20 years of experience in this area of research, we specialize in the unique challenges associated with nephrology populations.

Learn More

Hematology / Oncology

CTI has unparalleled experience in working with complex and critically ill patients.

Learn More

Neurology / Sleep Research

CTI has a long history of working in neurology including rare/orphan diseases, central nervous system (CNS) disorders, psychiatry, and sleep research. We've contributed to the development programs of 16 sleep focused drug approvals.

Learn More

Infectious Diseases

Our experience in this area is specific to complex immunocompromised patient populations susceptible to opportunistic infections.

Learn More

Hepatology

We specialize in the unique challenges associated with hepatic populations, from mild to moderate liver disease to end stage acute and chronic liver disease.

Learn More

Cardiopulmonary

CTI’s expertise includes regulatory and clinical operations personnel who understand the intricate and interdependent characteristics of cardiopulmonary research.

Learn More

Pediatric / Neonate Populations

The CTI team has diverse experience in pediatric and neonate populations in both clinical study management and regulatory consulting across a wide array of indications.

Learn More

Devices

CTI has significant experience in device and in vitro diagnostic (IVD) development across a multiple therapeutic areas.

Learn More